Cargando…

Children and Adolescents with Chronic Myeloproliferative Neoplasms: Still an Unmet Biological and Clinical Need?

Detalles Bibliográficos
Autores principales:	Mughal, Tariq I., Deininger, Michael W., Kucine, Nicole, Saglio, Giuseppe, Van Etten, Richard A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919464/ https://www.ncbi.nlm.nih.gov/pubmed/31942538 http://dx.doi.org/10.1097/HS9.0000000000000283

Ejemplares similares

Chronic Myeloproliferative Neoplasms: Some Remaining Challenges
por: Mughal, Tariq I., et al.
Publicado: (2018)

Interrogating the molecular genetics of chronic myeloproliferative malignancies for personalized management in 2021
por: Mughal, Tariq I., et al.
Publicado: (2021)

Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: Treatment Considerations and Unmet Needs
por: Liu, Angela, et al.
Publicado: (2022)

Illuminating novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignancies
por: Mughal, Tariq I., et al.
Publicado: (2020)

CALR mutation characterization in myeloproliferative neoplasms
por: Bilbao-Sieyro, Cristina, et al.
Publicado: (2016)

Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs
por: Sobas, Marta, et al.
Publicado: (2022)

Biology and Clinical Management of Myeloproliferative Neoplasms and Development of the JAK Inhibitor Ruxolitinib
por: Mascarenhas, J, et al.
Publicado: (2012)

New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms
por: Hasselbalch, Hans C., et al.
Publicado: (2021)

JAK2 in Myeloproliferative Neoplasms: Still a Protagonist
por: Bader, Michael Stephan, et al.
Publicado: (2022)

Meeting the Need for a Discussion of Unmet Medical Need
por: Horgan, Denis, et al.
Publicado: (2022)

Thromboinflammation in Myeloproliferative Neoplasms (MPN)—A Puzzle Still to Be Solved
por: Bhuria, Vikas, et al.
Publicado: (2022)

Unmet Needs for the Treatment of Chronic Hepatitis E Virus Infection in Immunocompromised Patients
por: Kamar, Nassim, et al.
Publicado: (2022)

The puzzle of myeloproliferative neoplasms: novel disease-specific mutations and new proposals for diagnostic criteria
por: Kim, Hee-Jin, et al.
Publicado: (2014)

P1724: QUALITY OF LIFE AND UNMET NEEDS AMONG PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASM PATIENTS: RESULTS OF THE NATIONWIDE SURVEY
por: Ionova, T., et al.
Publicado: (2022)

Unmet Needs for Palliation in Fibrotic Interstitial Lung Disease
por: Singhania, Sumeet Vimal Kishore, et al.
Publicado: (2018)

Retinitis Pigmentosa: Burden of Disease and Current Unmet Needs
por: Cross, Nancy, et al.
Publicado: (2022)

EAHP 2020 workshop proceedings, pediatric myeloid neoplasms
por: Leguit, R. J., et al.
Publicado: (2022)

Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper
por: Barbui, Tiziano, et al.
Publicado: (2019)

A novel assay to detect calreticulin mutations in myeloproliferative neoplasms
por: Rosso, Valentina, et al.
Publicado: (2016)

Still a burning question: the interplay between inflammation and fibrosis in myeloproliferative neoplasms
por: Gleitz, Hélène F.E., et al.
Publicado: (2021)

Unconditional cash transfer to reduce the burden of unmet surgical needs
por: Laverty, Robert B., et al.
Publicado: (2022)

Philadelphia-negative chronic myeloproliferative neoplasms
por: Bittencourt, Rosane Isabel, et al.
Publicado: (2012)

Myeloproliferative neoplasms
por: Cross, Nick
Publicado: (2019)

Myeloproliferative neoplasms
por: Kiladjian, Jean-Jacques
Publicado: (2018)

Molecular biology of Philadelphia-negative myeloproliferative neoplasms
por: Campregher, Paulo Vidal, et al.
Publicado: (2012)

Myeloproliferative neoplasms: From JAK2 mutations discovery to JAK2 inhibitor therapies
por: Passamonti, Francesco, et al.
Publicado: (2011)

Myelofibrosis-type megakaryocyte dysplasia (MTMD) as a distinct category of BCR::ABL-negative myeloproliferative neoplasms. Challenges and perspectives
por: Barosi, Giovanni, et al.
Publicado: (2023)

Is Treatment for Cytopenic Myelofibrosis Still an Unmet Clinical Need?
por: Caduc, Madeline J., et al.
Publicado: (2023)

Chronic Myeloproliferative Neoplasms: a Collaborative Approach
por: Pieri, Lisa, et al.
Publicado: (2010)

Coexistence of Chronic Lymphocytic Leukemia and Myeloproliferative Neoplasm
por: Zielinska, Patrycja, et al.
Publicado: (2014)

Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms
por: Marin Oyarzún, Cecilia P., et al.
Publicado: (2019)

Epigenetics in Myeloproliferative Neoplasms
por: McPherson, Suzanne, et al.
Publicado: (2017)

Aetiology of Myeloproliferative Neoplasms
por: McMullin, Mary Frances, et al.
Publicado: (2020)

The microenvironment in myeloproliferative neoplasm
por: Méndez-Ferrer, Simón, et al.
Publicado: (2018)

Spleen in myeloproliferative neoplasms
por: Barosi, Giovanni
Publicado: (2018)

Epigenetics in myeloproliferative neoplasms
por: Greenfield, Graeme, et al.
Publicado: (2023)

Bcl‐xL represents a therapeutic target in Philadelphia negative myeloproliferative neoplasms
por: Petiti, Jessica, et al.
Publicado: (2020)

Global Blindness: The Progress We Are Making and Still Need to Make
por: Taylor, Hugh R.
Publicado: (2019)

The Role of New Technologies in Myeloproliferative Neoplasms
por: Palumbo, Giuseppe A., et al.
Publicado: (2019)

An Unmet Need: Surgical Gloves with Variable Finger Lengths
por: Rudolph, Ross, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_63m52rqjocv2jnvrug7p0kvpif